Atlas Trials

Real-world Study of Acalabrutinib

Clinical trial NCT06767891 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT06767891
Sponsor
Ruijin Hospital
Status
ENROLLING_BY_INVITATION
Study type
OBSERVATIONAL
MCLCLL
Start date
2024-07-02
Primary completion
2026-07-30
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.